You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD-40

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Tumor-infiltrating Lymphocytes (TIL)
  • +5 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Non Small Cell Lung Cancer, Lung Cancer Trial in Bronx (drug, biological, radiation)

Recruiting
  • Non Small Cell Lung Cancer
  • Lung Cancer
  • FLT3 Ligand (CDX-301)
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jul 18, 2022

Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)

Recruiting
  • Metastatic Triple Negative Breast Cancer
  • PLD Chemotherapy
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jun 23, 2022

Immune Thrombocytopenic Purpura Trial in Sohag (Genotyping of rs1883832C/T related single-nucleotide polymorphism)

Not yet recruiting
  • Immune Thrombocytopenic Purpura
  • Genotyping of rs1883832C/T related single-nucleotide polymorphism
  • Sohag, Egypt
    Sohag University hospitals
Oct 16, 2022

Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)

Recruiting
  • Healthy Adults
  • Solo 0.3 group
  • +5 more
  • Créteil, France
  • +2 more
Sep 9, 2022

Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • odetiglucan
  • CDX-1140
  • (no location specified)
Jul 29, 2022

Carcinoma, Squamous Cell, Head and Neck Tumor, Cervical Tumor Trial in Southampton (BNT113)

Recruiting
  • Carcinoma, Squamous Cell
  • +3 more
  • Southampton, Hampshire, United Kingdom
    Univeristy Hospitals Southampton NHS Foundation Trust
May 17, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

Recruiting
  • Metastatic Pancreatic Cancer
  • MesoPher
  • Mitazalimab
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Dec 6, 2022

Cancer Trial in Houston (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Houston, Texas
    MD Anderson Cancer Center
Apr 4, 2022

Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)

Recruiting
  • Type 1 Diabetes Mellitus
  • Vancouver, British Columbia, Canada
    Investigational Site Number : 1240001
Oct 31, 2023

Non-CNS Tumor Trial (biological, drug, radiation)

Not yet recruiting
  • Non-CNS Tumor
  • GEN1042
  • +2 more
  • (no location specified)
Aug 4, 2022

Melanoma Trial in Houston (APX005M, Pembrolizumab)

Recruiting
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40

Recruiting
  • Advanced Malignant Solid Tumor
  • MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
  • Lyon, Cedex 08, France
  • +3 more
Nov 4, 2022

Melanoma, Carcinoma, Non-Small- Cell Lung Trial in Worldwide (SEA-CD40, pembrolizumab, pemetrexed)

Recruiting
  • Melanoma
  • Carcinoma, Non-Small- Cell Lung
  • Springdale, Arkansas
  • +18 more
Mar 11, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (SL-172154)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +8 more
Feb 23, 2022

Cancer, Solid Tumor, Cancer of Skin Trial in New York (2141 V-11)

Recruiting
  • Cancer
  • +2 more
  • 2141 V-11
  • New York, New York
    Rockefeller University
Mar 15, 2022

Cancer Trial in Beijing (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Beijing, Beijing, China
    Center Hospital Chinese Academy of Medical Sciences
Dec 7, 2021

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer Trial (Pegylated Liposomal Doxorubicin +

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • Pegylated Liposomal Doxorubicin + SL-172154
  • Mirvetuximab + SL-172154
  • (no location specified)
Jul 29, 2022